Clinical programs for inhaled insulin have received several setbacks of late, with Bagsværd, Denmark-based Novo Nordisk deciding in January to terminate phase 3 trials of its inhaler and ...
Riker Laboratories advertised its new device for treating asthma in 1957—two years after a teenager’s truly inspiring suggestion. Courtesy Mark Sanders In April 1955, 13-year-old Susie Maison asked ...
Trelegy Ellipta (fluticasone/umeclidinium/vilanterol) is an inhaled medication used to treat chronic obstructive pulmonary disease (COPD) and asthma in adults. Common ...
New molecular entities (NMEs) are produced at the same rate today as they were 50 years ago. The industry has averaged one NME per company every 6 years, and its most successful firms have averaged ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results